TY  - JOUR

T1  - Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer.

JO  - Health technology assessment (Winchester, England)

UR  - http://eprints.whiterose.ac.uk/43321/

PY  - 2010/10/01

AU  - Whyte S

AU  - Pandor A

AU  - Stevenson M

AU  - Rees A

ED  - 

DO  - DOI: 10.3310/hta14suppl2/07

VL  - 14

IS  - Suppl. 2

SP  - 47

EP  - 53

Y2  - 2024/12/22

ER  -